679 related articles for article (PubMed ID: 33256663)
21. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
Malley DS; Barone R; Heinemann MH
Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
[TBL] [Abstract][Full Text] [Related]
22. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients.
Schneider EW; Elner SG; van Kuijk FJ; Goldberg N; Lieberman RM; Eliott D; Johnson MW
Retina; 2013 Oct; 33(9):1791-9. PubMed ID: 23584702
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
Ufret-Vincenty RL; Singh RP; Lowder CY; Kaiser PK
Am J Ophthalmol; 2007 Feb; 143(2):334-5. PubMed ID: 17258523
[TBL] [Abstract][Full Text] [Related]
24. Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.
Boss JD; Rosenberg K; Shah R
J Pediatr Ophthalmol Strabismus; 2016 Oct; 53():e58-e60. PubMed ID: 27783090
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus retinitis in a patient of granulomatosis with polyangiitis on long-term immunosuppressants.
Reddy S; Tyagi M; Behera S; Pappuru RR
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542003
[TBL] [Abstract][Full Text] [Related]
26. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic options for resistant cytomegalovirus retinitis.
Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.
Jabs DA; Enger C; Dunn JP; Forman M
J Infect Dis; 1998 Mar; 177(3):770-3. PubMed ID: 9498461
[TBL] [Abstract][Full Text] [Related]
30. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
31. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus retinitis treated with ganciclovir in a renal transplant recipient.
Horng IH; Chen MS; Lee PH; Chen YC; Lee CS; Hou PK
Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1152-5. PubMed ID: 2561486
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
34. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
35. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
36. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus Retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone.
Singh R; Singh R; Trehan A; Jain R; Bhalekar S
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e118-9. PubMed ID: 23042013
[TBL] [Abstract][Full Text] [Related]
38. Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy.
Adler H; De Gascun CF; McSweeney F; Acheson RW; Brannigan ET; Duffy M; Keegan DJ; Lambert JS
Int J STD AIDS; 2014 Oct; 25(11):827-9. PubMed ID: 24516078
[TBL] [Abstract][Full Text] [Related]
39. Clinical profile and immunological status of cytomegalovirus retinitis in organ transplant recipients.
Wagle AM; Biswas J; Gopal L; Madhavan HN
Indian J Ophthalmol; 2002 Jun; 50(2):115-21. PubMed ID: 12194567
[TBL] [Abstract][Full Text] [Related]
40. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
Levi ME; Mandava N; Chan LK; Weinberg A; Olson JL
Transpl Infect Dis; 2006 Mar; 8(1):38-43. PubMed ID: 16623819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
